Compare $BCAB vs $MTNB | Chartloom

Compare

$BCAB vs $MTNB

Bioatla Inc · Matinas BioPharma Holdings Inc

BCAB

Bioatla Inc

MTNB

Matinas BioPharma Holdings Inc

Compare $BCAB vs $MTNB

Comparing Bioatla Inc and Matinas BioPharma Holdings Inc

BCABBioatla Inc

MTNBMatinas BioPharma Holdings Inc

BCABBioatla Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-22.7%

YTD performance

-94.4%

52W performance

-96.7%

FCF yield

-943.1%

MTNBMatinas BioPharma Holdings Inc

Market cap

$39M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-89.8%

FCF yield

-16.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAB

MTNB

Detailed metrics comparison

BCAB

Bioatla Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

BCAB$2M

MTNB$39M

Enterprise Value

BCAB$946K

MTNB$39M

Price

BCAB$1.50

MTNB$2.87

P/E Ratio

BCABN/A

MTNBN/A

P/S Ratio

BCAB0.29x

MTNB0.60x

EV/Sales

BCAB0.11x

MTNB0.43x

EV/EBITDA

BCAB0.00x

MTNB0.00x

P/B Ratio

BCAB4.57x

MTNB1.44x

P/FCF Ratio

BCABN/A

MTNBN/A

EV/FCF

BCAB-0.04x

MTNB-6.00x

PEG Ratio

BCABN/A

MTNBN/A

Forward P/E (NTM)

BCABN/A

MTNBN/A

Forward P/S (NTM)

BCABN/A

MTNBN/A

Revenue (TTM)

BCAB$9M

MTNB$0

Revenue Growth (YoY)

BCAB-22.7%

MTNBN/A

Forward Rev Growth

BCAB0.0%

MTNB0.0%

Gross Margin (TTM)

BCAB0.0%

MTNB0.0%

Operating Margin (TTM)

BCAB0.0%

MTNB0.0%

EBITDA Margin (TTM)

BCAB-369.8%

MTNB0.0%

Net Margin (TTM)

BCAB-370.0%

MTNB0.0%

FCF Margin (TTM)

BCAB-276.3%

MTNBN/A

Net Income (TTM)

BCAB$-31M

MTNB$-3M

FCF (TTM)

BCAB$-23M

MTNB$-6M

EPS (TTM)

BCAB-$18.93

MTNB$0.00

ROE (TTM)

BCAB-35792.0%

MTNB-13745.0%

ROA (TTM)

BCAB-26317.0%

MTNB-9202.0%

ROIC (TTM)

BCAB-35792.0%

MTNB-13717.0%

Cash

BCAB$2M

MTNB$761K

Debt

BCAB$0

MTNB$6K

Net Cash/Debt

BCAB$2M

MTNB$755K

Current Ratio (TTM)

BCAB0.20x

MTNB0.85x

Quick Ratio (TTM)

BCAB0.17x

MTNB0.60x

Debt/Equity (TTM)

BCAB0.00x

MTNB0.00x

Debt/Assets (TTM)

BCAB0.0%

MTNB0.0%

Interest Coverage (TTM)

BCABN/A

MTNBN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

MTNB0.00x

Beta

BCAB0.63

MTNB2.20

52W Performance

BCAB-96.7%

MTNB-89.8%

YTD Performance

BCAB-94.4%

MTNB-69.1%

% from 52W High

BCAB-97.9%

MTNB-90.1%

% from 52W Low

BCAB40.2%

MTNB27.1%

Asset Turnover (TTM)

BCAB0.73x

MTNB0.09x

FCF Yield (TTM)

BCAB-943.1%

MTNB-16.3%

Earnings Yield (TTM)

BCAB-1263.2%

MTNB-8.8%

Dividend Yield (TTM)

BCABN/A

MTNBN/A

Rule of 40

BCAB-299.0

MTNB0.0

EV/GP/RG

BCABN/A

MTNBN/A

Ticker research

View BCAB research View MTNB research

Metric	BCAB Bioatla Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$2M	$39M
Enterprise Value	$946K	$39M
Price	$1.50	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	0.60x
EV/Sales	0.11x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-3M
FCF (TTM)	$-23M	$-6M
EPS (TTM)	-$18.93	$0.00
ROE (TTM)	-35792.0%	-13745.0%
ROA (TTM)	-26317.0%	-9202.0%
ROIC (TTM)	-35792.0%	-13717.0%
Financial Health
Cash	$2M	$761K
Debt	$0	$6K
Net Cash/Debt	$2M	$755K
Current Ratio (TTM)	0.20x	0.85x
Quick Ratio (TTM)	0.17x	0.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.20
52W Performance	-96.7%	-89.8%
YTD Performance	-94.4%	-69.1%
% from 52W High	-97.9%	-90.1%
% from 52W Low	40.2%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.09x
FCF Yield (TTM)	-943.1%	-16.3%
Earnings Yield (TTM)	-1263.2%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View MTNB research

Valuation

P/S Ratio

BCAB

0.29x

MTNB

0.60x

EV/FCF

MTNB

-6.00x

BCAB

-0.04x

Growth & revenue

Revenue Growth TTM

BCAB

-22.7%

Forward Revenue Growth

BCAB

0.0%

MTNB

0.0%

Profitability & performance

Gross Margin

BCAB

0.0%

MTNB

0.0%

ROE

MTNB

-13745.0%

BCAB

-35792.0%

FCF Yield %

MTNB

-16.3%

BCAB

-943.1%

52-Week Performance

MTNB

-89.8%

BCAB

-96.7%

Detailed metrics comparison

BCAB

Bioatla Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

BCAB$2M

MTNB$39M

Enterprise Value

BCAB$946K

MTNB$39M

Price

BCAB$1.50

MTNB$2.87

P/E Ratio

BCABN/A

MTNBN/A

P/S Ratio

BCAB0.29x

MTNB0.60x

EV/Sales

BCAB0.11x

MTNB0.43x

EV/EBITDA

BCAB0.00x

MTNB0.00x

P/B Ratio

BCAB4.57x

MTNB1.44x

P/FCF Ratio

BCABN/A

MTNBN/A

EV/FCF

BCAB-0.04x

MTNB-6.00x

PEG Ratio

BCABN/A

MTNBN/A

Forward P/E (NTM)

BCABN/A

MTNBN/A

Forward P/S (NTM)

BCABN/A

MTNBN/A

Revenue (TTM)

BCAB$9M

MTNB$0

Revenue Growth (YoY)

BCAB-22.7%

MTNBN/A

Forward Rev Growth

BCAB0.0%

MTNB0.0%

Gross Margin (TTM)

BCAB0.0%

MTNB0.0%

Operating Margin (TTM)

BCAB0.0%

MTNB0.0%

EBITDA Margin (TTM)

BCAB-369.8%

MTNB0.0%

Net Margin (TTM)

BCAB-370.0%

MTNB0.0%

FCF Margin (TTM)

BCAB-276.3%

MTNBN/A

Net Income (TTM)

BCAB$-31M

MTNB$-3M

FCF (TTM)

BCAB$-23M

MTNB$-6M

EPS (TTM)

BCAB-$18.93

MTNB$0.00

ROE (TTM)

BCAB-35792.0%

MTNB-13745.0%

ROA (TTM)

BCAB-26317.0%

MTNB-9202.0%

ROIC (TTM)

BCAB-35792.0%

MTNB-13717.0%

Cash

BCAB$2M

MTNB$761K

Debt

BCAB$0

MTNB$6K

Net Cash/Debt

BCAB$2M

MTNB$755K

Current Ratio (TTM)

BCAB0.20x

MTNB0.85x

Quick Ratio (TTM)

BCAB0.17x

MTNB0.60x

Debt/Equity (TTM)

BCAB0.00x

MTNB0.00x

Debt/Assets (TTM)

BCAB0.0%

MTNB0.0%

Interest Coverage (TTM)

BCABN/A

MTNBN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

MTNB0.00x

Beta

BCAB0.63

MTNB2.20

52W Performance

BCAB-96.7%

MTNB-89.8%

YTD Performance

BCAB-94.4%

MTNB-69.1%

% from 52W High

BCAB-97.9%

MTNB-90.1%

% from 52W Low

BCAB40.2%

MTNB27.1%

Asset Turnover (TTM)

BCAB0.73x

MTNB0.09x

FCF Yield (TTM)

BCAB-943.1%

MTNB-16.3%

Earnings Yield (TTM)

BCAB-1263.2%

MTNB-8.8%

Dividend Yield (TTM)

BCABN/A

MTNBN/A

Rule of 40

BCAB-299.0

MTNB0.0

EV/GP/RG

BCABN/A

MTNBN/A

Ticker research

View BCAB research View MTNB research

Metric	BCAB Bioatla Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$2M	$39M
Enterprise Value	$946K	$39M
Price	$1.50	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	0.60x
EV/Sales	0.11x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-3M
FCF (TTM)	$-23M	$-6M
EPS (TTM)	-$18.93	$0.00
ROE (TTM)	-35792.0%	-13745.0%
ROA (TTM)	-26317.0%	-9202.0%
ROIC (TTM)	-35792.0%	-13717.0%
Financial Health
Cash	$2M	$761K
Debt	$0	$6K
Net Cash/Debt	$2M	$755K
Current Ratio (TTM)	0.20x	0.85x
Quick Ratio (TTM)	0.17x	0.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.20
52W Performance	-96.7%	-89.8%
YTD Performance	-94.4%	-69.1%
% from 52W High	-97.9%	-90.1%
% from 52W Low	40.2%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.09x
FCF Yield (TTM)	-943.1%	-16.3%
Earnings Yield (TTM)	-1263.2%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View MTNB research